Clinical Trial Update: XmAb20717 in Advanced Biliary Tract Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for XmAb20717 in advanced biliary tract cancers, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• XmAb20717

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Biliary Tract Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING